Walker S. Lahr

1.9k total citations · 1 hit paper
21 papers, 1.0k citations indexed

About

Walker S. Lahr is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Walker S. Lahr has authored 21 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 13 papers in Oncology and 6 papers in Genetics. Recurrent topics in Walker S. Lahr's work include CRISPR and Genetic Engineering (14 papers), CAR-T cell therapy research (13 papers) and Virus-based gene therapy research (6 papers). Walker S. Lahr is often cited by papers focused on CRISPR and Genetic Engineering (14 papers), CAR-T cell therapy research (13 papers) and Virus-based gene therapy research (6 papers). Walker S. Lahr collaborates with scholars based in United States and Japan. Walker S. Lahr's co-authors include Beau R. Webber, Branden S. Moriarity, Mitchell G. Kluesner, Derek Nedveck, John Garbe, Juan E. Abrahante, Emily J. Pomeroy, Matthew J. Johnson, Branden A. Smeester and Cara-lin Lonetree and has published in prestigious journals such as Nature Communications, Blood and PLoS ONE.

In The Last Decade

Walker S. Lahr

21 papers receiving 1.0k citations

Hit Papers

EditR: A Method to Quantify Base Editing from Sanger Sequ... 2018 2026 2020 2023 2018 100 200 300

Peers

Walker S. Lahr
Bian Hu China
Lupeng Ye China
Meena Subramaniam United States
In-Young Jung United States
Jon P. Connelly United States
Bian Hu China
Walker S. Lahr
Citations per year, relative to Walker S. Lahr Walker S. Lahr (= 1×) peers Bian Hu

Countries citing papers authored by Walker S. Lahr

Since Specialization
Citations

This map shows the geographic impact of Walker S. Lahr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Walker S. Lahr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Walker S. Lahr more than expected).

Fields of papers citing papers by Walker S. Lahr

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Walker S. Lahr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Walker S. Lahr. The network helps show where Walker S. Lahr may publish in the future.

Co-authorship network of co-authors of Walker S. Lahr

This figure shows the co-authorship network connecting the top 25 collaborators of Walker S. Lahr. A scholar is included among the top collaborators of Walker S. Lahr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Walker S. Lahr. Walker S. Lahr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kluesner, Mitchell G., Emily J. Pomeroy, Joseph G. Skeate, et al.. (2025). Precision enhancement of CAR-NK cells through non-viral engineering and highly multiplexed base editing. Journal for ImmunoTherapy of Cancer. 13(5). e009560–e009560. 8 indexed citations
2.
Laoharawee, Kanut, Walker S. Lahr, Joseph J. Peterson, et al.. (2024). Development and testing of a versatile genome editing application reporter (V-GEAR) system. Molecular Therapy — Methods & Clinical Development. 32(2). 101253–101253. 1 indexed citations
3.
Lahr, Walker S., et al.. (2023). CRISPR-Cas9 base editors and their current role in human therapeutics. Cytotherapy. 25(3). 270–276. 11 indexed citations
4.
Spartz, Ellen J., Walker S. Lahr, Yun You, et al.. (2023). Germline T cell receptor exchange results in physiological T cell development and function. Nature Communications. 14(1). 528–528. 2 indexed citations
5.
Webber, Beau R., Matthew J. Johnson, Joseph G. Skeate, et al.. (2023). Cas9-induced targeted integration of large DNA payloads in primary human T cells via homology-mediated end-joining DNA repair. Nature Biomedical Engineering. 8(12). 1553–1570. 12 indexed citations
6.
Roy, Nand Kishor, Keman Zhang, Abhishek Asthana, et al.. (2022). A BAFF ligand-based CAR-T cell targeting three receptors and multiple B cell cancers. Nature Communications. 13(1). 217–217. 59 indexed citations
7.
Skeate, Joseph G., Walker S. Lahr, Nicholas J. Slipek, et al.. (2022). 392 Engineering CD70-directed CAR-NK cells for the treatment of hematological and solid malignancies. Regular and Young Investigator Award Abstracts. A413–A413. 1 indexed citations
8.
Lahr, Walker S., et al.. (2022). Abstract A021: Chimeric antigen receptor armored natural killer cell immunotherapy for osteosarcoma. Clinical Cancer Research. 28(18_Supplement). A021–A021. 1 indexed citations
9.
Kluesner, Mitchell G., Walker S. Lahr, Anthony P. DeFeo, et al.. (2022). Correction of Fanconi Anemia Mutations Using Digital Genome Engineering. International Journal of Molecular Sciences. 23(15). 8416–8416. 5 indexed citations
10.
Laoharawee, Kanut, Matthew J. Johnson, Walker S. Lahr, et al.. (2022). A Pan-RNase Inhibitor Enabling CRISPR-mRNA Platforms for Engineering of Primary Human Monocytes. International Journal of Molecular Sciences. 23(17). 9749–9749. 1 indexed citations
11.
Tabdanov, Erdem D., Alexander X. Cartagena‐Rivera, Emily J. Pomeroy, et al.. (2021). Engineering T cells to enhance 3D migration through structurally and mechanically complex tumor microenvironments. Nature Communications. 12(1). 2815–2815. 90 indexed citations
12.
Kluesner, Mitchell G., Walker S. Lahr, Cara-lin Lonetree, et al.. (2021). CRISPR-Cas9 cytidine and adenosine base editing of splice-sites mediates highly-efficient disruption of proteins in primary and immortalized cells. Nature Communications. 12(1). 2437–2437. 74 indexed citations
13.
Choi, Eugene, Walker S. Lahr, Emily J. Pomeroy, et al.. (2021). Engineering CD70-Directed CAR-NK Cells for the Treatment of Hematological and Solid Malignancies. Blood. 138(Supplement 1). 1691–1691. 20 indexed citations
14.
Laoharawee, Kanut, et al.. (2020). Genome Engineering of Primary Human B Cells Using CRISPR/Cas9. Journal of Visualized Experiments. 10 indexed citations
15.
Laoharawee, Kanut, M. J. Johnson, Walker S. Lahr, et al.. (2020). Genome Engineering of Primary Human B Cells Using CRISPR/Cas9. Journal of Visualized Experiments. 3 indexed citations
16.
Pomeroy, Emily J., John Hunzeker, Mitchell G. Kluesner, et al.. (2019). A Genetically Engineered Primary Human Natural Killer Cell Platform for Cancer Immunotherapy. Molecular Therapy. 28(1). 52–63. 139 indexed citations
17.
Webber, Beau R., Cara-lin Lonetree, Mitchell G. Kluesner, et al.. (2019). Highly efficient multiplex human T cell engineering without double-strand breaks using Cas9 base editors. Nature Communications. 10(1). 5222–5222. 155 indexed citations
18.
Johnson, Matthew J., Kanut Laoharawee, Walker S. Lahr, Beau R. Webber, & Branden S. Moriarity. (2018). Engineering of Primary Human B cells with CRISPR/Cas9 Targeted Nuclease. Scientific Reports. 8(1). 12144–12144. 62 indexed citations
19.
Kluesner, Mitchell G., Derek Nedveck, Walker S. Lahr, et al.. (2018). EditR: A Method to Quantify Base Editing from Sanger Sequencing. The CRISPR Journal. 1(3). 239–250. 314 indexed citations breakdown →
20.
Kurata, Morito, Natalie K. Wolf, Walker S. Lahr, et al.. (2018). Highly multiplexed genome engineering using CRISPR/Cas9 gRNA arrays. PLoS ONE. 13(9). e0198714–e0198714. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026